Image of the Month: The greenhouse inside the lab
In addition to conducting groundbreaking biomedical research, Baylor College of Medicine is also creating better foods to address global food security issues.
Read More
Not all cell types age equally – the Aging Fly Cell Atlas reveals how this happens
The new atlas provides a powerful, open-access resource for scientists to better understand the biology of aging.
Read More
Innovative machine-learning program reveals genes responsible for sex-specific differences in Alzheimer’s disease
This approach, called Evolutionary Action Machine Learning, enables researchers to probe smaller cohorts with greater accuracy.
Read More
New biotech venture PHIOGEN, a spinoff of BCM’s TAILOR Labs, to tackle the global threat of antimicrobial resistance
PHIOGEN has developed a world-first technology platform that mobilizes the natural power of bacteriophages to tackle critical and life-threatening infections.
Read More
Delivering on the promise of personalized breast cancer therapy
A test predicts with a high degree of confidence which breast cancer patients would benefit the most from a therapy de-escalation approach.
Read More
Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response
The findings in animal models warrant continuing investigations to develop a novel, more effective and longer-lasting cancer therapy.
Read More
Major primate genome sequencing studies reveal new insight into evolution, biodiversity and key applications for human health
These studies improve our understanding of both human biology and practical clinical issues.
Read More
Gene Tiam1 orchestrates the development of chronic neuropathic pain
The findings open new possibilities for novel therapies to provide much needed relief to patients with this condition.
Read More
Changes in gene p16 create a permissive microenvironment for colon cancer growth
The researchers also developed a strategy that reduced tumor growth and improved survival in tumor-bearing mice.
Read More
Breast cancer tumors remotely disrupt immune response that could stop their own growth
The researchers identified ways to accelerate the restoration of the normal immune response and the efficacy of immunotherapies in animal models.
Read More